Cookies on PerkinElmer
PerkinElmer uses cookies to ensure that we give you the best experience possible on our website. This may include cookies from third party websites. If you continue without changing your settings, we will assume that you consent to receive cookies from this website. You can change your cookie settings at any time. To learn more, please review our cookie policy, which includes information on how to manage your cookies.
Press Conference

Recent Media Coverage

Read recent articles about PerkinElmer below. Clicking a headline will take you to the publication’s website for the full article.

Top 10 Sequencing Companies

By 2022, the global next-generation sequencing (NGS) market has been projected to reach between $10.5 billion (BCC Research) and $12.45 billion (MarketsandMarkets), though a more cautious forecast envisions that market growing a bit more slowly, to $11.92 billion by 2024 (BIS Research).

Maternal Factors, Biomarkers Improve Preeclampsia Screening

First trimester screening for pre-eclampsia (PE) can be improved using a combination of maternal factors and biomarkers, according to a study published online March 14 in Ultrasound in Obstetrics & Gynecology.

Top Instrument Firms in 2017

C&EN's ranking of scientific equipment makers reflects strong sales to a broad range of customers.

New Hope for Treating Cerebral Palsy

A new study published in Stem Cells Translational Medicine may provide new hope for families with children born with CP, and a new treatment in doctors’ regimens for treating CP.

Expert view: Innovations in 3D

Physiologically relevant models to evaluate the effects of drug candidates early in the drug discovery and development process are becoming increasingly important to develop.

Stem Cells Show Promise For Treating Autism

ViaCord helped fund a small, but promising study that suggests stem cells from a child’s own cord blood may offer an effective treatment for autism symptoms.

Direct Analysis of Glyphosate in Wine

Experts describe the analysis of glyphosate in wine with no sample preparation using QSight 220 LC-MS/MS system with a ‘Stay Clean’ source.

The Rise of 3D Cell Culture Systems

The development of three-dimensional (3D) cell culture systems has greatly expanded over the past few decades.

A life-saving option

Banking your child’s cord blood could be the smartest thing you’ll ever do.

Looking for Mycotoxins in Dairy Products

If you are in the dairy business, you know the threats posed by mycotoxins, particularly aflatoxins B1, B2, G1, G2 and M1.

PerkinElmer beats 3Q profit forecasts

PerkinElmer Inc. (PKI) reported third-quarter profit of $58.1 million. The Waltham, Massachusetts-based company said it had net income of 53 cents per share. Earnings, adjusted for one-time gains and costs, were 68 cents per share.

Screening Newborn Babies for SCID

Severe combined immunodeficiency (SCID, or “bubble-boy disease”) is an inherited genetic condition resulting from a severe defect in the immune system that makes it difficult or impossible for the affected individual to fight off infections.

Beyond the Moon

The launch of a new data sharing initiative in cancer genomics has been welcomed by doctors and data scientists alike.

New Portable GC-MS System for Field Analysis

Visitors to PerkinElmer at WWEM, stand 60, will be able to find out more about the new Torion T-9 Portable GC-MS system for analyses in the field.

Securing the Global Food Supply Chain

Many of the foods and drinks we consume every day are not as safe as we think. Despite increasingly stringent safety regulations, food fraud, adulterated products, and ingredients containing harmful chemicals or pathogens continue to slip through the global safety net to sicken an estimated 600 million people every year.

PerkinElmer Beats 2Q Profit Forecasts

PerkinElmer shares have climbed 4 percent since the beginning of the year, while the Standard & Poor's 500 index has risen roughly 6 percent.

Cord blood banking remains 'personal decision'

“Donating cord blood for public use or storing it for a family’s private use is really a personal decision,” says Del Steckler, cord blood recruitment manager with Be the Match.